SPO Medical Launching Enhanced PulseOx 7500 Oximetry System
New York, NY - SPO Medical Inc. (SPOM), a leading developer of biosensor and microprocessor technologies for use in portable monitoring devices, recently announced that it has released its PulseOx 7500 supporting GUI (graphic user interface) and report generation in multiple languages including French, Italian, German and Spanish ("FIGS") along with English. The Company believes by supporting FIGS languages it will be able to address the growing interest in the PulseOx 7500 across European markets and the Spanish speaking markets of the Americas.
Millions of people suffer from sleep apnea worldwide. Sleep apnea is a sleep disorder characterized by pauses in breathing during sleep. Each episode, called apneas, lasts long enough so that one or more breaths are missed, and occurs repeatedly throughout sleep disturbing a person's sleep pattern. Symptoms may be present for years, even decades without identification, during which time the sufferer may become conditioned to the daytime sleepiness and fatigue associated with significant levels of sleep disturbance. Such fatigue is known to be the cause of road accidents, industrial accidents and reduction in performance at the work place.
Typically, people with sleep disorder symptoms are referred by their primary care physician to third-party sleep clinics for overnight monitoring at the clinic facility, and depending on the diagnosis, are prescribed an appropriate medical remedy. The PulseOx 7500 designed for maximum comfort and flexibility, enables doctors and other medical professionals to monitor patients from the convenience of the patient's home. Data is collected and stored overnight by wearing the PulseOx 7500 wrist-watch configuration while the user sleeps; the next morning, the data is easily downloaded by the family care or general practitioner for analysis using supplied reporting software.
"We are delivering this new product feature as a direct result of increased demand from our European sales distributors. Those caring for sleep apnea sufferers recognize the value proposition of the PulseOx 7500 and our cost-effective product is now available to a wider multi-language community as an effective pre-screening device for detecting sleep disorders in the comfort of a patient's home," commented Michael Braunold, President and CEO of SPO Medical. Mr. Braunold continued, "Introducing the additional languages once again demonstrates our commitment to extend our technological applications to meet the diverse needs of our worldwide customer base."
To date SPO Medical has introduced several other devices currently selling in close to 40 countries worldwide that use the Company's proprietary Reflective Pulse Oximetry (RPO) technology for accurate and reliable measurements of blood oxygen saturation (SpO2) and heart rate; they include the PulseOx 5500 - a stand-alone homecare spot check monitor; Check Mate - a device for the sports and aviation markets that demand measuring SpO2 and heart rate during high-altitude activities; PulseOx 6000, a professional stand-alone spot check monitor and the PulseOx 6100 which is a professional hand-held monitor. Most recently the Company announced its entry in to the homecare baby monitoring market with its first product due in 2009.
SOURCE: SPO Medical Inc.